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1. Introduction 
The term gastric adenoma means a benign lesion of the glandular epithelium having 
variable degrees of cellular atypia and showing papillary or tubular structures. Because 
long-term follow-up studies of gastric adenomas reveal malignant transformations, it is well 
known they are premalignant. Since these lesions lie histologically and clinically on the 
borderline of between whether they are benign or malignant, it is extremely important for 
clinicians to determine whether they are to be treated or not (Morson, 1980; Kamiya, 1982; 
Rugge, 1994).   
For a long time, there was no specific treatment policy of gastric adenomas and treatment 
varied from close endoscopic follow-ups to endoscopic resection, considering its 
heterogeneous clinical consequences (Di Gregorio, 1993; Saraga, 1987). When gastric 
epithelial dysplasia is classified using the two or three tier system, each group shows a 
different clinical course. For gastric adenoma with high grade dysplasia (HGD), endoscopic 
resection has become the standard treatment because of risk of malignant progression and 
synchronous carcinomas (Lansdown, 1990; Farinati, 1993). Many western publications have 
recommended close endoscopic follow-up of patients with moderate/low grade gastric 
epithelial dysplasia (Rugge, 1991, Fertitta, 1993; Rugge, 1991). The frequency of the follow-
up has been recommended to be every three to 12 months at least during the first year, but it 
is still unknown of how long the follow-up should be maintained for when no progression 
has been detected (Bearzi, 1994; Fertitta, 1993). The disadvantages of endoscopic follow-ups 
are patient anxiety, risk of disease progression, and low patient compliance for an undefined 
period (Lansdown, 1990; Rugge, 1991). Though endoscopic resection has become frequently 
applied for gastric adenoma with low grade dysplasia (LGD), there is ongoing controversy 
considering its relatively benign natural course and clinical significance. Although 
endoscopic resection is a less invasive procedure than surgical resection, it still carries the 
risk of complications and requires hospitalization of several days (Ono 2001, O'Mahony, 
2001; Miyata 2000).  
Argon plasma coagulation (APC) is a kind of non-contact technique for tissue coagulation, 
which transfers high-frequency electric current through ionized argon gas to targeted 
lesions (Grund, 1994; Grunde, 1997). Because APC has an advantage of confining the 
thermal effect to the superficial layer of the gastrointestinal wall, APC has been used for 
the treatment of bleeding ulcers, hemorrhagic telangiectasias, and tumors (Chau, 2003; 
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Cipolletta, 1998; Iacopini, 2007). For the treatment of early gastric cancer, APC has been 
used on a limited number of patients due to it being impossible to get a pathologic 
evaluation and to predict the depth of invasion (Sagawa, 2003; Kitamura, 2006). 
Considering that gastric adenomas are confined to the mucosa and the thermal effect of 
APC is extended to both the mucosa and submucosa, theoretically the gastric adenoma 
lesion can be eradicated with APC. APC has the advantage of preventing excessive tissue 
damage and perforation, due to the coagulation damage of tissue increasing the electrical 
impedance, in turn decreasing the electrical current and automatically stopping 
irradiation (Goulet Watson, 2000; Morson, 1980). Based on the above characteristics of 
APC, it can most probably be the safer and most effective therapeutic option of treating 
gastric adenomas. However, it has been reported that some endoscopists have 
experienced an unexpected extension of tissue destruction and even perforation, which 
could have been due to host and technical factors. Therefore, APC has been proven not to 
be completely free from the risk of perforation (Hoyer, 1998; Prost, 2004). In this chapter, 
we will give a brief introduction about the APC procedure after the submucosal saline 
injection for the treatment of gastric adenomas at the out-patient clinic without any need 
for hospitalization. 
2. Gastric adenoma and its natural course 
Most adenomas present a pale surface, and few cases reveal redness on the surface. The 
frequency of gastric adenomas in different age groups reveals a tendency to increase 
markedly with aging, especially above the fifth decade. This tendency may have some 
relation to atrophic changes and especially intestinal metaplasia of the gastric mucosa 
among the aged (Morson, 1980; Kamiya, 1982; Rugge,1994). In some report, co-existent 
gastric carcinomas were more frequently found (8%) in the same stomach and meticulous 
endoscopic evaluation was required. Epidemiological and histopathological studies have 
shown that intestinal type gastric cancers frequently develop through a sequence of 
histological events: namely diffuse chronic gastritis, often mucosal atrophy, intestinal 
metaplasia (complete and/or incomplete), gastric adenoma, and finally invasive carcinoma 
(Rugge, 1994; Saraga, 1987). Several prospective and retrospective serological studies have 
now linked Helicobacter pylori infection to gastric cancer (Talley, 1991; Parsonnet, 1991; 
Nomura, 1991). Helicobacter pylori infection is clearly associated with the induction of chronic 
inflammation of the gastric mucosa and the progressive development of metaplastic changes 
(Asaka, 2006).  
Gastric adenoma is known to be a precancerous lesion of intestinal type adenocarcinoma 
and has diverse outcomes depending on the degree of dysplasia. According to the 
histological abnormality, gastric dysplasia has been graded using a two or three tier system- 
high/low or high/moderate/low grade dysplasia. Gastric adenoma with HGD was known 
to regress in about 5%, to persist in 14%, and to progress in 81–85% of cases (Miyata, 2000; 
Giovannini 1993). In chronological studies of malignant progression, the time period 
between diagnosis of HGD and gastric cancer varied and was between less than 1 month to 
39 months (Farinati, 1993; Fertitta, 1993). It is suggested the possibility that some of these 
lesions already contained carcinomatous lesions but the invasive element was not included 
in the original biopsy sample (Lansdown, 1990; Farinati 1993). Endoscopic resection 
methods such as endoscopic mucosal resection (EMR) or endoscopic submucosal dissection 
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(ESD) confirmed this possibility (Miyata, 2000; Giovannini, 1999; Watanabe, 2006). 
Therefore, gastric adenomas with HGD have to be treated as if it were an early gastric 
cancer, because of the risk of synchronous carcinoma and high risk of malignant progression 
(Farinati, 1993; Rugge, 1991).  
Gastric adenomas with LGD show a different natural course. Gastric adenomas with LGD 
have been reported to regress in 38–49%, to be persistent in 19–28%, to progress in 5–21%, 
and eventually to be diagnosed as gastric adenocarcinoma in 0–5% of cases (Fertitta, 1993; 
Rugge, 1991). Although many cases of gastric adenomas with LGD do not progress, a 
number of cases were reported to have done so, progressing to HGD or carcinoma after a 
median follow-up period ranging from 34.5 to 41.5 months (Fertitta, 1993; Rugge, 1991). This 
long interval time suggests that gastric adenomas with LGD rarely contain carcinoma at the 
time of diagnosis (Fertitta, 1993; Rugge, 1991).  
Many western publications recommended close endoscopic follow-up of gastric adenomas 
with LGD, every 3–12 months until no progression is detected (Bearzi, 1994; Fertitta 1993). 
However, this approach has many problems; patient anxiety, risk of disease progression, and 
low compliance with frequent and expensive follow-up for an undefined period. Provided that 
HGD has been confirmed with endoscopic biopsy, many authors suggest surgical or 
endoscopic resection. Endoscopic resection can offer a non-surgical solution for intramucosal 
adenocarcinoma with advances in endoscopic localization method (chromoscopy, NBI) and 
staging techniques (endoscopic ultrasound)(Ono, 2001; O’Mahony, 2001).  
3. Endoscopic resection of gastric adenoma  
Endoscopic resection methods such as EMR and ESD are already recognized as standard 
treatments of premalignant lesions and small intramucosal cancerous lesions (Giovannini, 
1999; Watanabe, 2006; Takenaka, 2008). Because a lesion is resected by means of 
electrocautery snaring using the EMR method, EMR is typically used for removal of lesions 
smaller than 2 cm or piecemeal removal of larger lesions. ESD has been developed for en 
bloc removal of large lesions (usually more than 2 cm) (Ono, 2001; O’Mahony, 2001). Using 
the ESD method, a circumferential mucosal incision and submucosal dissection is done with 
specialized endoscopic electrocautery knives after marking the lesion and then injecting 
saline into the submucosal layer (Oka, 2006; Takeuchi, 2007, Oka, 2006).  
Although EMR and ESD are less invasive procedures than surgical operations, they still 
carry some risk of complications such as bleeding and perforation, and require hospital 
admission for a few days (Oka 2006; Takeuchi, 2007). ESD requires the use of expensive 
specialized knives and a longer procedure time, and runs a higher risk of bleeding or 
perforation, as compared to EMR (Ono, 2001). Considering the risk of synchronous 
carcinoma and malignant progression, endoscopic resection is the best therapeutic option of 
gastric adenomas with HGD (Lansdown, 1990; Farinati, 1993). However, because gastric 
adenomas with LGD have a relatively benign natural course, endoscopic resection might be 
an excessive and expensive procedure (Rugge, 1995; Fertitta, 1993). From this point of view, 
the treatment of gastric adenomas with LGD should be different from the therapeutic option 
for gastric adenomas with HGD or intramucosal adenocarcinoma. In gastric adenomas with 
LGD, it can be recommended that therapeutic modalities between the frequent endoscopic 
follow-up and endoscopic resection be done, because a number of cases were reported to 
have progressed.  
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4. Argon plasma coagulation 
Argon plasma coagulation (APC) is a non-contact technique for tissue coagulation in 
which a high-frequency electrical current is transferred to the target tissue by means  
of ionized argon gas. An APC applicator for endoscopic use was developed in 1994, 
making it possible to provide tangential irradiation to coagulate a target lesion uniformly 
(Grund, 1994). APC has been introduced to treat a broad range of gastrointestinal 
problems, including bleeding ulcers (Chau, 2003; Cipolletta, 1998), Dieulafoy’s lesions 
(Iacopini, 2007), hemorrhagic telangiectasias (Olmos, 2006; Sato, 2005; Rolachon, 2000; 
Kwan, 2006; Nakamura, 2001), radiation proctitis (Kaassis, 2000; Postgate, 2007) and 
tumors (Sagawa, 2003; Kitamura, 2006). As the lesion becomes coagulated with APC 
irradiation, tissue electrical impedance sharply increases and electrical current abruptly 
decreases and is automatically transferred to surrounding tissue sites with low impedance 
(Grund 1994; Grund, 1997; Wahab, 1997). Therefore, APC irradiation can safely coagulate 
large areas of tissue within a short time and the excessive tissue damage can 
automatically be prevented (Wahab, 1997). This characteristic of APC confines the thermal 
effect to the superficial portion and is an advantage over conventional endoscopic 
cauterization. Therefore, APC seems to be the most popular non-contact technique for 
tissue coagulation in the gastrointestinal field.  
5. Argon plasma coagulation and early gastric cancer  
As economic development and medical advancement lengthen the life expectancy rate, the 
number of elderly patients with early gastric cancers who have a serious morbidity of being 
physically unable to withstand either surgical or endoscopic resection is increasing. Local 
ethanol injection (Imaoka, 1987), microwave coagulation (Tabuse, 1985), Nd:YAG laser 
treatment (Yasuda, 1993; Hiki, 1989; Sibille, 1995), and photodynamic therapy(Nakamura, 
1990; Ell, 1998; Mimura, 1996) have been applied in such cases. Nd:YAG laser treatment is 
widely used in treating patients with gastric cancers as a curative or palliative therapy but has 
the drawback of being impossible of being tangentially irradiated (Tajiri, 1991; Hiki, 1989). 
Sagawa et al (Sagawa, 2003) performed ex vivo experiments with swine gastric mucosal 
tissue in order to set the irradiation conditions of APC for the treatment of early gastric 
cancers based on histological analysis (Fig. 1). Under all output settings tested from 20  
to 100 W, the coagulation front became deeper as the duration of irradiation was 
prolonged, reaching a plateau after irradiation for 15 seconds with each power setting 
(Fig. 2). The ex vivo experiment demonstrated that the depth of coagulation could easily 
be adjusted by changing the irradiation time and current output. They recommended  
that irradiation at 60 W for 15 seconds (900 J/cm2) is the ideal setting for intramucosal 
cancer because this setting could cauterize the whole mucosal layer but would not affect 
the deep submucosal layer. However, there is a concern that the effect of APC observed in 
the ex vivo experiment would be somehow attenuated in vivo because there is blood flow 
that may act as a heat sink in living tissue. In addition, there was a concern of 
chronological changes of coagulation depth within a few days after APC irradiation. They 
applied the APC technique for the treatment of 27 patients with intramucosal gastric 
cancers who had no lymph node metastases (T1N0M0). APC showed a very high efficacy 
(no recurrence in 26/27 patients) after a follow-up period of 18–49 months (median 30 
months). High treatment efficacy was obtained in 12 of the 27 patients whose cancers 
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were located at difficult locations for the endoscope to access, the cardia or posterior wall 
of the gastric body, probably by virtue of tangential irradiation and uniform cauterization 
over a wide area. With regard to complications, some patients experienced a sense of 
abdominal fullness and it was easily alleviated by endoscopic suction during the 
procedure.  
 
 
 
Fig. 1. Macroscopic findings of swine gastric mucosa irradiated by argon plasma coagulation 
(APC) under various conditions. The effect of APC was macroscopically studied on swine 
gastric samples at 20, 40, 60, 80, and 100 W, with pulse durations of 5, 10, 15, and 20 seconds. 
The mucosa exposed to a greater output power of high frequency current and/or for a 
longer pulse duration underwent a more conspicuous color change from white to brown. 
(Quotation from Gut 2003;52:334–339 Sagawa T et al) 
Kitamura et al (Kitamura , 2006) applied APC for the treatment of early gastric cancers in 
40 patients who could not withstand surgical operation and endoscopic resection. There 
was no residual cancer or recurrence in 35 patients with intramucosal cancer after either a 
single session or multiple sessions of APC. In contrast, 3 patients (60%), who had large 
tumors and were treated with a single session of APC, had residual cancers or recurrence 
among the 5 patients with submucosal cancers after APC treatment. All residual cancers 
were eradicated after retreatment with additional APC. They also suggested that  
small early gastric cancers could be successfully treated with only a single session of APC, 
while large protruding-type tumors or submucosal cancers required two sessions of  
APC.   
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Fig. 2. Coagulation depth under various irradiation conditions based on histological analysis. 
The experiment was repeated twice using stomach specimens from two separate swine  
(Exp 1 and Exp 2). The coagulation front became deeper as the duration of irradiation was 
prolonged, reaching a plateau after irradiation for 15 seconds with each power setting. It was 
determined that the optimum treatment conditions of APC for clinical studies was a current of 
60 W and a maximum irradiation time of 15 s/cm2, which would not be expected to cause 
perforation. (Quotation from Gut 2003;52:334–339 Sagawa T et al)  
6. Argon plasma coagulation and gastric adenoma 
Although APC has been proven to be efficient for the treatment of mucosal and even 
submucosal cancers, it was only applied to the limited patients who were not suitable for 
surgical resection or EMR/ESD, because of drawbacks of APC including the inability to be 
histologically evaluated for the response to treatment immediately after the procedure, 
because it is impossible for a pathological specimen to be obtained with APC treatment 
(Sagawa, 2003; Kitamura, 2006).  Therefore, either surgical or endoscopic resection is usually 
preferred to APC treatment for patients whose physical condition is tolerable.  
The biologic behavior of adenomas is quite different from that of carcinomas. Because 
adenomas are limited and confined to the mucosal layer, gastric adenomas with LGD have 
no capacity to invade or infiltrate into deeper layers of the gastric wall (Di Gregorio, 1993; 
Saraga, 1987). As APC at optimal setting can totally cauterize the mucosal layer and 
superficial portion of submucosal layer, theoretically gastric adenomas can be clearly 
eradicated with APC. Different from gastric adenomas with HGD which should be treated 
as an early gastric cancer because of the risk of synchronous carcinoma and high risk of 
malignant progression, gastric adenomas with LGD rarely contain carcinomatous lesions at 
the time of diagnosis (Farinati, 1993; Fertitta, 1993). Based on these characteristics, APC 
treatment has many merits over endoscopic resection and frequent endoscopic follow-up; 
short procedure time, low risk of bleeding and perforation, low procedure cost, and no 
requirement of hospitalization. Therefore, it could be a reasonable treatment of gastric 
adenomas with LGD.  
APC treatment is characterized by non-contact coagulation, making it possible to provide 
tangential irradiation to coagulate a target site uniformly (Wahab, 1997; Wahab, 1997, Chau, 
2003). This feature is an advantage over other endoscopic cauterization such as local ethanol 
Exposure time (sec) 
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injection, Nd:YAG laser treatment, photodynamic therapy, and microwave coagulation 
(Tajiri, 1991; Ell, 1998). APC treatment method of gastric adenomas is similar to that of early 
gastric cancers. After a circumferential area around the lesion is marked with sufficient 
distance, irradiation is performed in the manner at 60-90 W for 15 seconds (900-1200 J/cm2), 
which makes the mucosa surface dry and the tissue to change from white to brown. 
Different from early gastric cancers in which one or two sessions of cauterization is usually 
required for eradication, one session of APC irradiation is sufficient for gastric adenomas 
because the depth of the lesion is limited. Inaccurate identification of boundary and the 
insufficient distance from the lesion to marking may be a more important factor of residual 
tumor after APC of gastric adenomas, as opposed to early gastric cancers. 
7. Argon plasma coagulation and thermal injury 
The thermal injury of APC is known to be confined to the mucosa and superficial 
submucosa layer and APC can theoretically prevent perforation. However, Kitamura et al 
(Kitamura, 2006) reported one case of perforation in 40 patients whose early gastric cancers 
were treated with APC. Fujishiro et al (Fujishiro, 2006; Fujishiro, 2008) investigated thermal 
tissue damage on the stomach of living minipigs to confirm the safety of APC, including a 
follow-up case. A minipig was sacrificed without delay after APC application, and a 
stomach specimen revealed that tissue damage was limited to the shallower submucosal 
layer regardless of the applied time (Fig. 1 and 2). The other was sacrificed after a one week 
follow-up, and its stomach specimen showed that granulomatous and fibrotic changes 
existed in the submucosal layer of the artificial ulcers at the pulse durations of 5 seconds and 
10 seconds. However, APC with pulse duration of 20 seconds created the deep ulceration 
with destruction of the proper muscle layer when examined after one week, which was not 
detected in the minipig sacrificed soon after APC application (Fig. 3).  
The thermal effects of APC have been studied in vitro with resected specimens of the 
stomach and other organs. Such models are limited to being evaluated to its biologic and 
healing response to thermal injury and the influence of digestive juices. Exposure of tissue 
directly to high temperatures causes an inflammatory response, coagulation necrosis, 
followed by desquamative necrosis. Immediately after exposure to thermal injury, histologic 
examinations of tissue specimens appeared normal, but necrosis occurred secondarily after 
formation of a nonvital layer (Fujishiro, 2006; Fujishiro, 2008). The electrical resistance of 
resected specimens is basically similar to that of the gastric mucosa in vivo. APC was 
reported to have tissue reaction of shrinkage, desiccation, coagulation, and devitalization 
from the applied surface to deep portion in order. Histological investigation may not detect 
the zone of devitalization, which means that tissue damage may be underestimated after 
APC treatment. APC is not completely safe from the risk of perforation, than we previously 
thought. This result suggests that we have to be aware of the risk of late perforation, which 
may occur a few days to a few weeks after APC application.  
8. Argon plasma coagulation and submucosal saline injection 
Previous experimental studies showed that thermal injury induced by APC was confined to 
the superficial area and deep tissue destruction caused by perforation was rare (Sagawa, 
2003; Watson, 2000). Clinical experiences with endoscopic evaluation also supported the 
rarity of perforation and safety of APC treatment. However, there is still the possibility of 
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the severe complication of perforation caused by APC as published in some reports 
(Yoshida, 2005; Fujishiro, 2008). And some studies indicated that APC-induced tissue 
damage could be extended to the proper muscle layer, which might lead to stricture or 
deformity of the gastrointestinal tract and also functional disturbance of the sphincter and 
peristaltic movement.  
 
 
Fig. 3. Correlation between the depth of tissue damage and pulse duration.  
The mean depth of the 4 observations is indicated as bars with a standard deviation  
in each condition. *m, the mucosal layer; ep, the epithelial layer; lpm, the lamina  
propria mucosae layer; mm, the muscularis mucosae layer; sm, the submucosal layer; 
 mp, proper muscle layer. A, Esophagus. B, Gastric upper third. C, Gastric middle third.  
D, Gastric lower third. E, Colon.  
(Quotation from Surg Laparosc Endosc Percutan Tech. 2006;16:307-11. Fujishiro et al) 
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Because the risk of deep tissue injury cannot be predicted, meticulous setting of electrical 
current, flow rate of argon gas, and irradiation duration need to be carefully monitored 
for a successful APC treatment, taking into consideration anatomical characteristics and 
patient condition. Differences in the extent of tissue damage due to APC may originate 
mainly from differences in the wall thickness and in the proportions of the wall 
components. In an experimental study using porcine tissue, the deepest tissue damage 
was observed in the colon after APC irradiation at the same setting conditions, probably 
because the colonic wall is much thinner than that of the other organs. From the parts of 
the stomach, the deepest tissue damage was observed in the upper third of the stomach at 
a 2-second pulse duration, which may also be because of the thinness of the mucosal wall 
(Fujishiro, 2006; Fujishiro, 2008).  
Submucosal injection of normal saline is an essential step for polypectomy and EMR for 
the prevention of bleeding and perforation (Fujishiro, 2004; Yoshida, 2005). The efficacy of 
submucosal injection of normal saline for the protection from thermal injury during APC 
was evaluated with animal studies (Norton, 2002; Fujishiro, 2006; Fujishiro, 2008).  
A minipig was sacrificed immediately after APC application, and its stomach specimen 
revealed that tissue damage deepened more as the applied time increased, but stayed 
confined to the mucosa and submucosa whether or not submucosal saline injections were 
done. The difference of depth of tissue injury was subtle between the two animal models, 
and the efficacy of submucosal saline injection was inconclusive in the immediate 
histopathologic evaluation of the specimen (Fujishiro, 2006; Fujishiro, 2008) (Fig. 4). An 
animal sacrificed one week after APC treatment revealed chronic inflammatory and 
fibrotic changes in the submucosal layer of the artificial ulcers and no injury of the proper 
muscle layer regardless of submucosal injection in the case of 5 and 10 seconds of 
irradiation time. APC irradiation without submucosal saline injections of a longer 
duration of 20 seconds only deepened the ulceration into the deep proper muscle layer. 
However, thermal injury after APC treatment of 20 seconds did not extend to the proper 
muscle layer in the animal with submucosal saline injection (Fig. 5). Therefore, 
submucosal saline injections are more likely to prevent the occasional deep tissue injury 
and the significant complication of perforation after long time irradiation of APC 
(Fujishiro, 2006; Fujishiro, 2008).  
The reason of this discrepancy of tissue damage with and without follow-up may be the 
limitations of histology to evaluate thermal damage, especially the devitalization zone. 
Histological investigations may not be able to detect the zone of devitalization 
immediately after tissue damage with APC and it can underestimate the range of damage 
than the true one. These results have two important clinical meanings. First, there is a risk 
of deep tissue destruction after APC treatment and follow-up studies are needed to 
evaluate the damaged lesion. Second, submucosal injection of normal saline before APC 
may be useful to decrease deep tissue destruction and to prevent perforation in a living 
body. Other studies using a resected stomach specimen showed the usefulness of 
submucosal injection before APC. The study of Fujishiro et al (Fujishiro, 2006; Fujishiro, 
2008) using a living minipig showed that APC irradiation after submucosal injection can 
limit thermal injury and prevent perforation not only immediately after procedure but 
also during the follow-up period.  
In practice, some endoscopists’ experienced an unexpected extension of tissue destruction 
and even perforation, which may be affected by various factors; host factors (mucosal and 
submucosa thickness, blood flow, inflammation, etc), technical factors (the extension of 
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the gastric wall by inflated air, the irradiation angle, the distance between an applicator 
and tissue, irradiation duration, etc) (Postgate, 2007; Sagawa, 2003). Therefore, 
submucosal injection of normal saline may be the effective and practical method to 
prevent extensive damage to the proper muscle layer at any encountered situation.  
 
 
 
Fig. 4. Tissue injury in a minipig sacrificed immediately after APC. A) APC (5 seconds) 
without prior submucosal injection. B) APC (5 seconds) after submucosal injection. C) APC 
(10 seconds) without prior submucosal injection. D) APC (10 seconds) after submucosal 
injection. E) APC (20 seconds) without prior submucosal injection. F) APC (20 seconds) after 
submucosal injection. Tissue coagulation was limited to the deeper submucosal layer under 
all the conditions. The thermal effects tended to deepen with a longer pulse duration and no 
prior saline injection. With prior saline injection, the increased thickness of the submucosal 
layer might prevent injury to the deeper submucosal layer. (Quotation from Gut Liver. 
2008;2:95-8. Fujishiro M et al) 
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Since tissue damage up to the submucosal layer is considered sufficient for the treatment of 
gastric adenoma and intramucosal carcinoma, submucosal injections of saline has a high 
possibility of becoming the standard preparation prior to APC application in humans.  
 
 
 
 
 
Fig. 5. Tissue damage in a minipig sacrificed 1 week after APC. A) APC (5 seconds)  
without prior submucosal injection. B) APC (5 seconds) after submucosal injection.  
C) APC (10 seconds) without prior submucosal injection. D) APC (10 seconds) after 
submucosal injection. E) APC (20 seconds) without prior submucosal injection.  
F) APC (20 seconds) after submucosal injection. Under all the conditions except for 20 
seconds of APC without prior submucosal injection, granulomatous and fibrotic changes 
were evident in the submucosal layer of the artificial ulcer, although the actual muscle layer 
appeared intact. Deep ulceration that destroyed the muscle layer was evident for 20 seconds 
of APC without submucosal injection.   
(Quotation from Gut Liver. 2008;2:95-8. Fujishiro M et al) 
9. Gastric adenoma treatment with APC and submucosal saline injection 
Gastric adenoma is a precursor lesion of gastric cancer and is usually classified using a 
two-grade system, divided into LGD and HGD (Lansdown, 1990, Farinati, 1993). Gastric 
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adenoma with HGD has a significant risk of disease progression and containing cancerous 
lesions, and it should be removed using an endoscopic resection procedure (Lansdown, 
1990, Farinati, 1993). Although endoscopic resection is a less invasive procedure than 
surgical resection, it carries the risk of various complications and requires hospitalization 
of several days (Watanabe, 2006; Fujishiro, 2004, Yoshida, 2005). Gastric adenoma with 
LGD is a less progressive disease than HGD; nevertheless, it carries some risk of disease 
progression (Rugge, 1995; Fertitta, 1993). The risk factors of developing gastric adenoma 
are chronic atrophic gastritis, intestinal metaplasia, Helicobacter pylori infection, old age, 
cigarette smoking, and alcohol drinking (Talley, 1991; Parsonnet, 1991; Nomura, 1991). 
These risk factors induce irreversible mucosal changes and can provide an environment 
for gastric tumors to occur at multiple sites (Talley, 1991; Parsonnet, 1991; Nomura, 1991). 
Patients at risk also have an increased chance of developing metachronous lesions, and  
a meticulous endoscopic follow-up should be done after treatment of gastric adenoma.  
Considering the less progressive nature of gastric adenomas with LGD, new less invasive 
and feasible treatment methods as opposed to endoscopic resection are needed, because it 
has a higher risk of procedure-related complications, need for hospitalization and high 
medical expenses. 
Gastric adenomas are confined to the mucosa of the gastric wall but are also located in reach 
of thermal effect of APC (Morson, 1980; Kamiya, 1982). Although APC is known to be an 
effective and safe procedure for early gastric cancers, bleeding control, and eradication of 
vascular lesions, they carry some risk of perforation due to the deep thermal effect. Based on 
the results of the animal study of Fujishiro et al (Fujishiro, 2006; Fujishiro, 2008), we have 
opted to use APC with submucosal saline injections (APC–SSI) to treat gastric adenomas 
with LGD. We have included submucosal saline injections as part of the routine procedure 
of APC for raising the mucosa and prevention of bleeding and perforation. It can be applied 
prior to APC to form an insulating fluid cushion in the submucosal layer to limit the thermal 
effect within the mucosa and superficial submucosal layer. The reduced risk of perforation 
and bleeding has lead to APC-SSI being available on an outpatient department (OPD) basis 
without requirement of hospitalization.  
We have evaluated the effectiveness of APC–SSI for gastric adenomas with LGD on  
OPD basis. We conducted a study of 57 patients with a combined total of 64 lesions of 
gastric adenomas with LGD, including patients who were not suitable for EMR/ESD due 
to bleeding tendency, serious concomitant disease, poor general condition, and advanced 
age (Table 1) (Lee, 2009). Gastric adenomas larger than 20 mm, accompanied with surface 
depression or nodularity, or containing HGD were excluded because of the possibility of 
co-existing cancerous tissue.  
The argon gas flow rate was 2.0 L/min, and the electrical current was set at 60 W. APC 
treatment was performed under sedation with midazolam and propofol. After spraying 
indigocarmine solution onto the lesion, the area around the lesion was marked using an 
APC probe. Normal saline solution was injected into the submucosal layer under the 
lesion with a standard disposable 25-G injection needle. Sometimes, indigocarmine 
solution would be mixed with normal saline for better identification of the submucosal 
layer. Normal saline-mixed solution was injected until sufficient submucosal swelling was 
achieved. The lesion and neighboring mucosa inside the marked sites were evenly treated 
with APC until the lesion was completely coagulated and appeared dry under endoscopic 
examination (Fig. 6).  
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Fig. 6. Endoscopic view of APC-SSI. A) Whitish discolored, flat surfaced, and slightly elevated 
lesion is noted at the greater curvature side of the distal antrum. B) After indigocarmine 
solution spraying, the boundary of the lesion is clearly distinct and a granular surface is 
visible. C) Surrounding markings were done with an APC probe with sufficient distance from 
the lesion. D) The size of lesion was measured by comparative ratio with 6 mm sized round 
piece of vinyl. E) Normal saline or sometimes normal saline-indigocarmine mixture solution 
was injected to the submucosal layer under the lesion with a standard 25-G injection needle. F) 
Normal saline solution was injected until sufficient submucosal swelling was achieved. G, H) 
The lesion and neighboring mucosa inside the marked sites were evenly coagulated with APC 
until the lesion was completely coagulated and appeared dry under endoscopic examination.  
After APC–SSI treatment, patients were closely observed. If there was no specific complaint, 
patients were discharged from hospital with proton pump inhibitor. On the occasion of severe 
pain or discomfort, patients were admitted to hospital. After discharge, follow- up endoscopic 
examinations with forceps biopsy was performed at 3, 6, and 12 months and then every 12 
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months. Lesions found at the same site as the previous lesion were defined as being residual. 
On the other hand, lesions found at a different site were considered to be metachronous. The 
treatment outcomes of all patients are shown in Table 1 and 93.7% of gastric adenomas were 
eradicated with APC–SSI. Four residual lesions (6.3%) were found at previous treated sites and 
they were gastric adenomas with LGD during mean follow-up time of 5.8 ± 3.2 months (range 
3–9 months) (Table 2). Three of these were located at the posterior wall of the upper and mid 
body. One lesion was located in the prepylorus. The initial lesions were incompletely 
coagulated probably because their locations were difficult to be accessed with an endoscope.  
For instance, the prepyloric lesion extending through the pyloric channel into the mucosa of 
the duodenal side was incompletely treated with APC probably due to the limitation of 
endoscopic visual field (Fig. 7). All of the residual adenomas were eradicated with additional 
APC–SSI treatment and did not reappear during follow-up. 
 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
Gender (men-women)    45/12 
 
Mean age, yr    59.5 ± 10.9 (34-81) 
 
Macroscopic type    Flat elevated type    58 
 
     Central depressed type     6 
 
Patients with concomitant diseases   32 (56.1%) (COPD, 8; liver cirrhosis, 6;  
     heart failure, 5; renal failure on hemodialysis 
     or peritoneal dialysis, 4; others, 9) 
 
Patients who refused hospitalization 25 (43.8%) 
for EMR and with a risk of perforation  
or bleeding 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
EMR, Endoscopic mucosal resection 
Table 1. Characteristics of 57 patients with a combined total of 64 lesions of gastric adenoma 
treated with APC-SSI 
 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
 Patient      Age,    Gender        Location                            Pathologic                Further 
    No.          yr                                                                            type                 treatment 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
 1                  66           M        P/W of Upper body     Adenoma c LGD        APC-SSI 
 2                  56           M        P/W of Upper body     Adenoma c LGD        APC-SSI 
 3                  70           M        P/W of Mid body         Adenoma c LGD        APC-SSI 
 4                  59           M        G/C of Prepylorus       Adenoma c LGD        APC-SSI 
 ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
P/W, Posterior wall; G/C, Greater curvature; LGD, Low grade dysplasia;  
APC-SSI, Argon plasma coagulation with submucosal saline injection 
Table 2. Characteristics of 4 patients with residual adenoma 
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Fig. 7. A case of treatment failure. Residual tumor was found 6 months after APC-SSI for 
prepyloric lesion. A) Round flat elevated lesion was located at greater curvature side of 
the distal antrum and prepylorus and has relatively clear margin. B, C) After marking 
with APC and submucosal saline injection, the lesion and surrounding mucosa was 
evenly coagulated. D) Follow-up endoscopy at 6 months after APC-SSI, a nodular 
surfaced elevated mass lesion with fold change was noted. Pathologic examination of 
biopsy specimen revealed gastric adenoma with LGD. E, F) After marking procedure and 
submucosal saline injection, the remnant lesion on the antrum was eradicated with APC 
treatment. G, H) With retroflexion of the endoscope, the lesion had extended into the 
duodenal bulb. After marking procedure and submucosal saline injection, the remnant 
lesion on the duodenal side was eradicated with additional APC treatment with 
retroflexion in the bulb. I) Follow-up endoscopy 1yr after additional treatment revealed 
healing ulcer scar without tumor recurrence.  
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Fig. 8. The case of metachronous intramucosal adenocarcinoma and gastric adenoma after 
APC-SSI. A) A slightly elevated lesion with smooth surface was noted at the greater 
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curvature side of the mid antrum. Endoscopic biopsy revealed Helicobacter gastritis.  
B) Whitish discolored, flat elevated lesion with clear margin was noted at the lesser 
curvature side of the gastric angle. C) After indigocarmine spraying, its surface revealed a 
lobular appearance. D) About 25 x 24 mm sized APC-induced round ulceration was noted 
at the lesser curvature side of the gastric angle. The ulcer base was blue-colored due to the 
submucosa injection of indigocarmine mixed saline. E) Endoscopic finding at 6 months 
after APC-SSI showed scarring ulceration with reddish regenerative epithelium.  
F) Endoscopic findings at 12 months showed a small elevated lesion with nodular  
surface at the greater curvature side of the antrum. Forceps biopsy results revealed 
intramucosal adenocarcinoma.G) For the treatment of the lesion, ESD was done.  
H) A large ESD-induced ulcer was seen without bleeding or perforation.  
I) A metachronous flat elevated round lesion was found at the lesser curvature side  
of the cardia during a follow-up endoscopy 2 years later. Forceps biopsy results  
revealed it was a gastric adenoma with LGD. J) Based on patient age and tumor location, 
APC-SSI was successfully done to treat the lesion. K) Endoscopic finding at 6 months  
after the second APC-SSI showed an ulcer scar. There was no evidence of residual  
tumor with endoscopic biopsy. 
Fourteen metachronous lesions were found in eight patients (14.0%) during follow-up 
(Table 3). Twelve lesions of gastric adenomas with LGD were treated with additional 
APC–SSI. One lesion of gastric adenoma with HGD was treated with ESD and it was 
proven to be intramucosal adenocarcinoma (Fig. 8). The other one with intramucosal 
adenocarcinoma was treated with APC–SSI because of poor general condition and 
bleeding tendency. Mean interval from treatment to detection of metachronous lesion was 
18.1 ± 11.6 months.  
Mean procedure time for APC-SSI was 15.0±5.0 (8–30) min. Transient abdominal discomfort 
occurred in 11 patients. Three complications (4.7%), including Mallory-Weiss tearing, 
pneumoperitoneum, and delayed bleeding, were noted (Table 4). Mallory–Weiss tearing 
was successfully controlled using endoscopic hemoclippings. Pneumoperitoneum occurred 
in a patient with two broad lesions at the lesser curvature side of the mid and upper body 
after a longer duration of APC-SSI. Endoscopy the next day showed broad ulcerative lesions 
with a coagulated base without evidence of perforation. The patient was hospitalized and 
discharged after 2 days of conservative care. Several authors reported one case each of APC-
induced pneumoperitoneum after treatment of acute hemorrhagic radiation proctitis 
(Chung, 2005; Hoyer, 1998; Manes, 2007). Pneumoperitoneum, however, does not 
necessarily mean perforation. It can be caused by air leakage through a partially coagulated 
wall by elevated intraluminal pressure. In our study, argon gas flow rate was 2 L/min. The 
long procedure time of APC inevitably induced marked stomach distention and increased 
intragastric pressure, probably resulting in air leaking into the peritoneal cavity without a 
visible perforation site of the gastric wall. Delayed bleeding from the regenerative vessels on 
the APC-induced ulcer occurred in one patient 2 weeks after the procedure and it was 
successfully managed with additional APC. APC is an effective noncontact technique for 
bleeding control (Islam, 2009; Grund, 1994; Grund, 1997) and there was no procedure-
related bleeding during and immediately after APC–SSI. This delayed bleeding was not 
caused by the APC procedure itself but by the healing and regenerative process, indicating 
that APC may be a safe treatment of gastric adenoma in patients with bleeding risk. This can 
also bring about stressful retching and Mallory–Weiss tearing. Therefore, frequent suction of 
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intragastric gas during procedure is helpful for the prevention of marked gastric distention 
and barotraumas.  
 
 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
 Patient Age Gender     Time(mon) Pathologic type  Further treatment 
 No 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
 1 51 M  9 Adenoma c LGD  APC-SSI 
 2 78 M  6 Adenoma c LGD   APC-SSI 
 3 49 M  12 Adenoma c LGD   APC-SSI 
 4 66 M  30 Intramucosal cancer  APC-SSI 
 5 59 F  5 Adenoma c LGD   APC-SSI 
    19 Adenoma c LGD   APC-SSI 
 6 50 M  6 Adenoma c LGD   APC-SSI 
    20 Adenoma c LGD   APC-SSI 
 7 51 M  12 Intramucosal cancer  ESD 
 8 49 M  43 Adenoma c LGD   APC-SSI 
    12 Adenoma c LGD   APC-SSI 
    19 Adenoma c LGD   APC-SSI 
    28 Adenoma c LGD   APC-SSI 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
P/W, Posterior wall; G/C, Greater curvature; LGD. Low grade dysplasia; 
APC-SSI, Argon plasma coagulation with submucosal saline injection;  
ESD, Endoscopic submucosal dissection 
Table 3. Characteristics of 14 metachronous lesions of 8 patients 
 
 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━              
 Mean duration of follow-up (mo)    19.5 ± 15.1 (6-49) 
 
 Mean time required for treatment (min)    15.0 ± 5.0 
 
 Patients with complications    3 (4.7%) 
 
 Mallory Weiss tearing                                         1 
 
 Pneumoperitoneum                                           1 
 
 Delayed bleeding                                             1 
 
 Patients with residual adenoma                               4 (7.0%) 
  
 Patients with metachronous adenoma                8 (14.0%) 
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ 
Table 4. Outcomes of endoscopic argon plasma coagulation with submucosal saline injection 
treatment (n=64) 
There are two important viewpoints in this study. One is the importance of the accurate 
identification of the lateral margin of the lesion. Because gastric adenomas are confined to 
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the mucosal layer and the entire lesion can be ablated with APC, residual lesions may be left 
near the lateral margin but away from the deep layer (Morson, 1980, Rugge, 1995). Lesion 
marking should include a sufficient amount of normal tissue around the lesion to ensure a 
successful APC-SSI, preventing treatment failure, as seen in EMR or ESD. Unlike colorectal 
or esophageal lesions whose margins are rather easy to delineate with indigocarmine or 
Lugol spraying, the margins of gastric tumors are sometimes difficult to diagnose, because 
the background mucosa is affected by acute or chronic inflammation or intestinal 
metaplasia. Because indigocarmine accumulates in the grooves and emphasizes the surface 
structural changes of the mucosa, it is difficult to identify the margin of the lesion which 
surface change is not distinct. Therefore, it could result in incomplete resection with positive 
lateral margin in EMR or ESD, and also leave residual tissue in those who receive APC 
treatment for adenomas. Inability to perform histopathologic evaluation of resected 
specimen is a shortcoming of APC treatment of gastric adenomas and we recommend 
sufficient margin to be obtained before APC-SSI for the prevention of residual tissue. 
Therefore, endoscopists should pay more attention to the lesions at difficult sites for 
endoscopic approach, such as the posterior wall of the upper and mid body, making sure 
there is sufficient margin from the lesions.  
The other viewpoint is the high prevalence of metachronous lesions after APC-SSI for 
gastric adenomas. We found 14 metachronous lesions in eight patients, and their locations 
were different from their original lesions during a mean of 19.5 months of follow-up. 
Those who have risk factors of gastric adenomas, including chronic atrophic gastritis, 
intestinal metaplasia, Helicobacter pylori infection, old age, cigarette smoking, and alcohol 
drinking, are more likely to develop metachronous lesions even after APC treatment. 
Chronic atrophic gastritis and intestinal metaplasia are known to be irreversible and may 
work as a continuous background of gastric cancer to recur at other sites (Talley, 1991; 
Parsonnet, 1991; Nomura, 1991). Because patients who have risk factors of gastric 
adenomas have an increased risk of metachronous lesions, meticulous endoscopic follow-
up should be done after the treatment of gastric adenomas (Talley, 1991; Parsonnet, 1991; 
Nomura, 1991).  
10. Conclusion 
Gastric adenomas are well-known as premalignant lesions of gastric cancer. Gastric 
adenomas with LGD show a relatively benign natural course and low risk of progression, 
compared with gastric adenomas with HGD. Though endoscopic resection has become the 
standard treatment of intramucosal carcinomas and adenomas with HGD, there is 
controversy about the therapeutic option of gastric adenomas with LGD. APC-SSI is the 
most reasonable and feasible treatment being safe and effective, which can be done in place 
of endoscopic resection and repeated endoscopic follow-up.  
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certainly be more therapeutic. It started with endoscopic hemostasis and polipectomy, than beginning of the
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endoscopy is now very complex and takes a lot of time for endoscopists to learn properly these techniques.
This book is a very good up-to-date overview of new techniques of interventional endoscopy for those who
want to learn or develop their knowledges in this field.
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